 3, 6, 12 months, and annually after.
 More frequent surveillance may be considered for individuals with abnormalities on DUS
The SVS does not have standard surveillance guidelines for patients undergoing catheter based
intervention for ALI.

146

Teaching Case
Scenario
A 73-year-old woman with a past medical history of HTN, HLD, Type 2 Diabetes, and Atrial
Fibrillation (on xarelto) presents